Siemens Healthineers AG

Siemens Healthineers AG

SHL · XETRA · Healthcare / Medical Devices

40.85EUR+0.78 (+1.95%)

Price History

Full chart

Market Stats

Previous Close40.07
Open40.38
Day Range40 – 40.87
52-Week Range32.81 – 48.54
Volume990.47K
Market Cap41.91B
P/E (TTM)19.01
Forward P/E15.70
EPS1.97
Dividend Yield2.64%
Beta0.83
50-Day Avg38.62
200-Day Avg38.22

About

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers in Germany, the United States, rest of Europe, CIS, Africa, the Middle East, the Americas, the Asia Pacific, Japan, and China. It operates in four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment offers magnetic resonance imaging, computed tomography, X-ray, molecular imaging, and ultrasound systems; and software solutions to support the reading and structured reporting of diagnostic images from different modalities. Its Diagnostics segment provides in-vitro diagnostic products and services to healthcare providers in the fields of general and specialty laboratory, and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment offers microwave, cryoablation, and embolization technologies, as well as clinical professional services for cancer care that support oncology departments in hospitals and clinics; and customized support for cancer care operations. Its Advanced Therapies segment provides products that are designed to support image-guided minimally invasive clinical procedures in various areas, such as cardiology, neurology, and oncology; angiography systems and mobile C-arms; and AI-powered clinical applications. It also offers essential technical customer service, such as maintenance and repair; spare parts; medical equipment performance management; training; clinical education and e-learning; planning and design; financing; asset management; and managed departmental services for laboratories and healthcare facilities, as well as healthcare consulting, products, and services. It has strategic partnership with IFS and Novo. The company was founded in 1896 and is headquartered in Forchheim, Germany. Siemens Healthineers AG is a subsidiary of Siemens Aktiengesellschaft.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEODr. Bernhard Montag Ph.D.
  • Employees74.30K
  • HeadquartersSiemensstr. 3, Forchheim, Germany, 91301, Germany
  • Websitehttps://www.siemens-healthineers.com

Leadership

  • Dr. Bernhard Montag Ph.D.President, CEO & Chairman of Management Board · b. 1969
  • Dr. Jochen Schmitz Ph.D.CFO & Member of Management Board · b. 1966
  • Ms. Darleen CaronChief Human Resources Officer, Labor Director & Member of Management Board · b. 1964
  • Ms. Elisabeth Staudinger-Leibrecht M.A.Member of Management Board · b. 1970
  • Ms. Astrid Kristine PlossMember of Supervisory Board, Head of Legal Advanced Therapies & Head of Legal Technology Excellence · b. 1970
  • Mr. Marc KoebernickHead of Investor Relations
  • Matthias KraemerHead of Corporate Communications
  • Christian KlaussnerExecutive Vice President of Finance
  • Ms. Sharon J. BrackenHead of Diagnostics · b. 1971
  • Jerry WangHead of China

Financials

Income Statement

Line item2015-09-302016-09-302017-09-302018-09-302019-09-302020-09-302021-09-302022-09-302023-09-302024-09-302025-09-30
Total Revenue12.94B13.55B13.68B13.43B14.52B14.46B18.00B21.71B21.68B22.36B23.38B
Cost of Revenue7.87B8.08B7.98B7.96B8.72B8.88B11.04B13.58B13.97B13.89B14.35B
Gross Profit5.07B5.47B5.70B5.47B5.80B5.58B6.95B8.14B7.71B8.47B9.03B
Operating Income1.91B2.12B2.22B2.03B2.31B2.04B2.78B3.06B2.44B3.30B3.44B
EBITDA2.55B2.72B2.81B2.53B2.93B2.84B3.52B4.26B3.78B4.22B4.58B
Net Income1.28B1.31B1.38B1.26B1.57B1.41B1.73B2.04B1.51B1.94B2.14B
R&D1.05B1.15B1.25B1.28B1.33B1.34B1.55B1.78B1.87B1.92B1.96B
Interest Expense117.00M216.00M267.00M205.00M123.00M76.00M83.00M118.00M296.00M476.00M425.00M

Balance Sheet

Line item2015-09-302016-09-302017-09-302018-09-302019-09-302020-09-302021-09-302022-09-302023-09-302024-09-302025-09-30
Total Assets19.46B20.30B21.11B19.76B21.43B25.09B41.93B49.06B46.68B46.05B44.37B
Total Liabilities15.73B17.89B17.82B11.08B11.65B12.58B25.87B29.20B28.55B27.81B26.28B
Total Equity3.69B2.37B3.28B8.66B9.77B12.50B16.04B19.84B18.08B18.20B18.04B
Cash73.00M206.00M184.00M519.00M920.00M656.00M1.32B1.44B1.64B2.68B2.17B
Total Debt8.52B9.61B11.02B4.71B142.00M5.50B14.31B14.06B12.46B16.21B15.06B
Net Debt8.45B9.41B10.83B4.19B-779.00M4.85B12.99B-704.00M-1.01B13.53B12.89B

Cash Flow

Line item2015-09-302016-09-302017-09-302018-09-302019-09-302020-09-302021-09-302022-09-302023-09-302024-09-302025-09-30
Operating Cash Flow1.81B1.67B1.73B1.44B1.50B1.93B2.93B2.50B2.12B2.47B3.08B
Investing Cash Flow11.00M-436.00M-453.00M-743.00M-662.00M-1.91B-14.14B-868.00M-1.07B-666.00M-906.00M
Financing Cash Flow-1.77B-1.10B-1.28B-334.00M-469.00M-249.00M11.84B-1.64B-690.00M-1.30B-2.59B
Capital Expenditure356.00M424.00M466.00M530.00M579.00M557.00M674.00M852.00M838.00M696.00M818.00M
Free Cash Flow1.46B1.25B1.26B910.00M919.00M1.37B2.26B1.65B1.28B1.77B2.27B
Dividends Paid148.00M377.00M352.00M230.00M699.00M798.00M856.00M955.00M1.07B1.06B1.07B

Earnings

Report DateMay 4, 2017Feb 1, 2018May 3, 2018Jul 30, 2018Nov 5, 2018Jan 29, 2019May 2, 2019Jul 29, 2019Nov 3, 2019Feb 3, 2020May 4, 2020Aug 2, 2020Nov 1, 2020Jan 26, 2021May 3, 2021Jul 30, 2021Nov 3, 2021Feb 2, 2022May 4, 2022Aug 3, 2022Nov 8, 2022Feb 1, 2023May 16, 2023Aug 1, 2023Nov 8, 2023Feb 1, 2024May 7, 2024Jul 30, 2024Nov 6, 2024Feb 6, 2025May 6, 2025Jul 30, 2025Nov 5, 2025Feb 4, 2026May 6, 2026Jul 30, 2026Nov 5, 2026
EPS Estimate0.00-0.360.360.470.370.400.370.510.390.400.250.440.380.480.530.620.530.560.480.580.430.530.490.650.440.510.520.650.470.580.520.690.440.510.530.68
EPS Actual0.300.360.380.340.430.350.440.350.540.350.450.300.480.490.440.560.530.550.670.430.650.470.460.530.580.480.540.520.670.510.560.640.680.490.530.70-
Surprise--5.56%-5.56%-8.51%-5.41%10.00%-5.41%5.88%-10.26%12.50%20.00%9.09%28.95%-8.33%5.66%-14.52%3.77%19.64%-10.42%12.07%9.30%-13.21%8.16%-10.77%9.09%5.88%0.00%3.08%8.51%-3.45%23.08%-1.45%11.36%3.92%32.08%-
Timing--After-hoursAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-market

Key Statistics & Ratios

Market Cap41.91B
Enterprise Value39.63B
Trailing P/E19.01
Forward P/E15.70
PEG Ratio1.71
Price / Sales1.81
Price / Book2.18
EPS1.97
Book Value17.13
Revenue (TTM)23.17B
Gross Profit (TTM)9.04B
EBITDA4.02B
Profit Margin9.55%
Operating Margin16.41%
Return on Equity12.15%
Return on Assets4.48%
Shares Outstanding1.12B
Shares Float357.71M
Beta0.83
Dividend Yield2.64%
Dividend Rate1
Payout Ratio41.67%

Dividends

20261×
1.00Feb 6, 2026
20251×
0.95Feb 19, 2025
20241×
0.95Apr 19, 2024
20231×
0.95Feb 16, 2023
20221×
0.85Feb 16, 2022
20211×
0.80Feb 15, 2021
20201×
0.80Feb 13, 2020
20191×
0.70Feb 6, 2019